Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 21, 2025Frontiers in PharmacologyOpen Access

Improved survival and neurological outcomes with lysophosphatidylcholine supplementation in severe cardiac arrest model

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMuhammad ShoaibFujian Institute of Research on the Structure of MatterMNMitsuaki NishikimiHiroshima UniversityRCRishabh C. ChoudharyUniversity of Pittsburgh

Discussion

Loading...

Member takes

Implication

Supplementation with lysophosphatidylcholine improves survival rates and neurological outcomes in cardiac arrest, suggesting effective therapy options.

Key Points

  • LPC supplementation significantly improved 72-hour survival rates, indicating its potential in cardiac arrest treatment.
  • Combination therapy led to better outcomes than single LPC species, as shown by improved modified neurological deficit scores.
  • Administration of LPC reduced troponin I levels, signaling cardioprotection and improved heart function.
  • The study demonstrates the effectiveness of LPC therapy in severe cardiac arrest models, emphasizing its translational potential.

Cite This Study

Shoaib et al. (2025) studied this question.

synapsesocial.com/papers/68af50a7ad7bf08b1ead8fe5https://doi.org/10.3389/fphar.2025.1587776
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Responses of Tissues from the Brain, Heart, Kidney, and Liver to Resuscitation following Prolonged Cardiac Arrest by Examining Mitochondrial Respiration in Rats2015 · 43 citations
  2. 2Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association2020 · 9,483 citations
  3. 3Update on Anti-Inflammatory Molecular Mechanisms Induced by Oleic Acid2023 · 297 citations